![]() |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Saturday, July 19, 2008
|
Canavan diseaseDefinitionCanavan disease is an inherited condition that affects the breakdown and use (metabolism) of aspartic acid. Alternative NamesSpongy degeneration of the brain; Aspartoacylase deficiencyCausesCanavan disease is inherited as an autosomal recessive trait. It is more common among Ashkenazi Jews than in the general population. The lack of the enzyme, aspartoacylase, leads to a buildup of material called N-acetylaspartic acid in the brain. This causes the white matter of the brain to break down (deteriorate). SymptomsSymptoms usually begin in the first year of life. Parents tend to notice when a child is not reaching certain developmental milestones, including head control. Symptoms include:
Exams and Tests
Tests:
TreatmentTreatment aims to ease the symptoms of the disease. There is no specific treatment. Support GroupsAdditional information and resources are available from: Canavan Foundation 877-4-CANAVAN Outlook (Prognosis)With Canavan disease, the central nervous system breaks down. Patients are likely to become disabled. Death often occurs before 18 months of age. However, some patients live until they are teenagers or, rarely, young adults. Possible ComplicationsThis is often a fatal disorder. It includes severe disabilities such as:
When to Contact a Medical ProfessionalCall your health care provider if your child has any symptoms of Canavan disease. PreventionGenetic counseling is recommended for people who want to have children and have a family history of Canavan disease. Counseling should be considered if both parents are of Ashkenazi Jewish descent. For this group, DNA testing can almost always tell if one or both parents is a carrier. Rezvani I. Defects in Metabolism of Amino Acids. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Kliegman: Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 85.
Review Date: 5/15/2008 Reviewed By: Chad Haldeman- Englert, MD, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited. |